Area of research
Infectious Diseases · Health, Toxicology and Mutagenesis
Research interest
Research interests include COVID-19 Clinical Research Studies, Air Quality and Health Impacts, Chronic Obstructive Pulmonary Disease (COPD) Research, and SARS-CoV-2 and COVID-19 Research.
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS
Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
Swedish Covid-19 Investigation for Future Insights – A Population Epidemiology Approach Using Register Linkage (SCIFI-PEARL)
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience
Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom
Prospective observational study in patients with obstructive lung disease: NOVELTY design
Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme
S2k guideline for treatment of cutaneous lupus erythematosus – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)
Meta-analysis of genome-wide association studies of HDL cholesterol response to statins
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease
Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New‐Onset Rheumatoid Arthritis: A Nested Case–Control Study
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the <scp>EUSCLE</scp> database
Genome-wide Association Analysis of Blood-Pressure Traits in African-Ancestry Individuals Reveals Common Associated Genes in African and Non-African Populations
Novel childhood asthma genes interact with in utero and early-life tobacco smoke exposure
Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden